Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

726 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[Wasted Anti-Cancer Agents Due to Cancellations after Dispensing].
Fukuda M, Honda T, Uchida T, Nose S, Kodama Y, Hashizume J, Tsuchiya A, Matsuo K, Kamada M, Honda K, Ishii K, Yamaguchi H, Mukae H, Ashizawa K. Fukuda M, et al. Among authors: mukae h. Gan To Kagaku Ryoho. 2022 Aug;49(8):861-865. Gan To Kagaku Ryoho. 2022. PMID: 36046971 Japanese.
Dyspnea with a slow-growing mass in the breast.
Amenomori M, Sakamoto N, Ashizawa K, Hayashi T, Kohno R, Yamamoto K, Ishimoto H, Mukae H, Kohno S. Amenomori M, et al. Among authors: mukae h. Respiration. 2010;79(4):346-50. doi: 10.1159/000264663. Epub 2009 Dec 3. Respiration. 2010. PMID: 19955708 Free article. No abstract available.
Pharmacokinetic parameters of gefitinib predict efficacy and toxicity in patients with advanced non-small cell lung cancer harboring EGFR mutations.
Mizoguchi K, Nakamura Y, Sano K, Sato S, Ikegami Y, Motoshima K, Takemoto S, Ogawara D, Senju H, Sugasaki N, Ikeda T, Yamaguchi H, Nakatomi K, Fukuda M, Izumikawa K, Mukae H. Mizoguchi K, et al. Among authors: mukae h. Cancer Chemother Pharmacol. 2016 Aug;78(2):377-82. doi: 10.1007/s00280-016-3097-4. Epub 2016 Jun 23. Cancer Chemother Pharmacol. 2016. PMID: 27339148 Clinical Trial.
Amphiregulin triggered epidermal growth factor receptor activation confers in vivo crizotinib-resistance of EML4-ALK lung cancer and circumvention by epidermal growth factor receptor inhibitors.
Taniguchi H, Takeuchi S, Fukuda K, Nakagawa T, Arai S, Nanjo S, Yamada T, Yamaguchi H, Mukae H, Yano S. Taniguchi H, et al. Among authors: mukae h. Cancer Sci. 2017 Jan;108(1):53-60. doi: 10.1111/cas.13111. Epub 2016 Dec 30. Cancer Sci. 2017. PMID: 27783866 Free PMC article.
Primary Mediastinal Large B-cell Lymphoma Exhibiting Endobronchial Involvement.
Shimada M, Fukuda M, Horio K, Suyama T, Kitazaki T, Hashiguchi K, Fukuda M, Shigematsu K, Nakamura Y, Honda T, Ashizawa K, Mukae H. Shimada M, et al. Among authors: mukae h. Intern Med. 2016;55(21):3147-3150. doi: 10.2169/internalmedicine.55.7117. Epub 2016 Nov 1. Intern Med. 2016. PMID: 27803409 Free PMC article.
CT and MRI findings of thymic carcinoid.
Shimamoto A, Ashizawa K, Kido Y, Hayashi H, Nagayasu T, Kawakami A, Mukae H, Hayashi T, Ohtsubo M, Shigematsu K, Nakazono T, Yabuuchi H, Uetani M. Shimamoto A, et al. Among authors: mukae h. Br J Radiol. 2017 Mar;90(1071):20150341. doi: 10.1259/bjr.20150341. Epub 2017 Jan 20. Br J Radiol. 2017. PMID: 28106503 Free PMC article.
Phase I study of pemetrexed and concurrent radiotherapy for previously untreated elderly patients with locally advanced non-squamous non-small cell lung cancer.
Takemoto S, Nakamura Y, Fukuda M, Senju H, Gyotoku H, Taniguchi H, Shimada M, Ikeda T, Yamaguchi H, Nakatomi K, Hayashi N, Soda H, Mukae H. Takemoto S, et al. Among authors: mukae h. Thorac Cancer. 2017 Nov;8(6):577-581. doi: 10.1111/1759-7714.12483. Epub 2017 Aug 3. Thorac Cancer. 2017. PMID: 28771961 Free PMC article. Clinical Trial.
726 results